2007
DOI: 10.3892/ijmm.19.4.571
|View full text |Cite
|
Sign up to set email alerts
|

Improvement of organ damage by a non-depressor dose of imidapril in diabetic spontaneously hypertensive rats

Abstract: Many clinical trials have demonstrated that angiotensin converting enzyme inhibitors have protective effects on organ damage, suggesting the importance of inhibition of the renin-angiotensin system. In this study, we investigated the effects of a non-depressor dose of imidapril on organ damage induced by diabetes and hypertension. Diabetes was induced by an intravenous injection of streptozotocin (STZ, 40 mg/kg) in 15-week-old male spontaneously hypertensive rats (SHR). Imidapril (2 mg/ kg/day) or vehicle was … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2008
2008
2017
2017

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 42 publications
(57 reference statements)
0
3
0
Order By: Relevance
“…The aortic size was measured before and after laparotomy once per week up to 4 weeks after the operation. Blood pressure was measured in pre-warmed rats by the tail-cuff method (BP-98A; Softron Co., Tokyo, Japan) as previously reported (27).…”
Section: Materials Nifedipine Was Donated By Bayer Pharmaceuticalmentioning
confidence: 99%
“…The aortic size was measured before and after laparotomy once per week up to 4 weeks after the operation. Blood pressure was measured in pre-warmed rats by the tail-cuff method (BP-98A; Softron Co., Tokyo, Japan) as previously reported (27).…”
Section: Materials Nifedipine Was Donated By Bayer Pharmaceuticalmentioning
confidence: 99%
“…In particular, it plays a key role in the pathology of hypertension ( 3 ). In the renin-angiotensin system, angiotensin I (Ang I)-converting enzyme (ACE) hydrolyzes the inactive decapeptide Ang I by cleaving a dipeptide from the C-terminus to produce the potent vasoconstrictor Ang II, which is responsible for increasing arterial pressure ( 4 , 5 ). Therefore, the modulation of the renin-angiotensin system has become a promising approach for controlling blood pressure in the treatmente of cardiovascular disorders, for example by using ACE inhibitors as therapeutic agents.…”
Section: Introductionmentioning
confidence: 99%
“…First, nitric oxide production through eNOS is critical for protection, since (1) eNOS in the kidney is mainly expressed in the renal vascular endothelium, such as glomerular capillaries and renal arteries and arterioles, but not in cortical capillaries or venous endothelium [21] , although subtle tubular expression of eNOS also occurs in locations such as the inner medullary collecting duct [22] and the thick ascending limb of loop of Henle [23] and (2) nitric oxide plays an important role in the control of renal function through multiple mechanisms such as increasing renal blood flow by vasodilatation, increasing glomerular filtration rate [24] , and protecting the endothelium via its antiapoptotic effects. For instance, a nonhypotensive dose of an ACE inhibitor in diabetic SHR was shown to inhibit proteinuria through an increase in nitric oxide production via elevation of eNOS activity, and to result in an increase in urinary excretion of NOx [25] . On the other hand, genetic or pharmacologic inhibition of eNOS is reported to lead to development of renal abnormalities, including tubular cell death in eNOS knockout mice [26] and in nitro-L -arginine methyl estertreated subtotally nephrectomized rats [27] .…”
Section: Discussionmentioning
confidence: 99%